Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G del Peso

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactateR Selgas, M A Bajo, M J Fernandez-Reyes, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 30, 2008
[Anatomic-functional correlation of the peritoneal membrane]G del Peso, J A Jiménez-Hefferman, M A Bajo, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1994
CAPD for treatment of ESRD patients with ascites secondary to liver cirrhosisM A Bajo, R Selgas, C Jimenez, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 22, 2000
Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcomeC Jiménez, C Díaz, R Selgas, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 22, 2000
Tumor necrosis factor alpha as a uremic toxin: correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patientsM Espinoza, A Aguilera, M Auxiliadora Bajo, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 9, 2002
[Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions]M A Bajo, R Selgas, G del Peso, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1994
Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term studyR Selgas, M J Fernandez-Reyes, E Bosque, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|April 5, 2011
[Pleuroperitoneal communication in patients on peritoneal dialysis. One hospital's experience and a review of the literature]R Díaz Mancebo, G Del Peso Gilsanz, M Rodríguez, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 24, 2001
Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysisR Selgas, M A Bajo, M J Castro, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|August 21, 2001
Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivoM A Bajo, G del Peso, M A Castro, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1996
Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactateR Selgas, M A Bajo, M J Fernandez-Reyes, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 30, 2008
[Anatomic-functional correlation of the peritoneal membrane]G del Peso, J A Jiménez-Hefferman, M A Bajo, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1994
CAPD for treatment of ESRD patients with ascites secondary to liver cirrhosisM A Bajo, R Selgas, C Jimenez, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 22, 2000
Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcomeC Jiménez, C Díaz, R Selgas, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 22, 2000
Tumor necrosis factor alpha as a uremic toxin: correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patientsM Espinoza, A Aguilera, M Auxiliadora Bajo, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 9, 2002
[Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions]M A Bajo, R Selgas, G del Peso, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1994
Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term studyR Selgas, M J Fernandez-Reyes, E Bosque, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|April 5, 2011
[Pleuroperitoneal communication in patients on peritoneal dialysis. One hospital's experience and a review of the literature]R Díaz Mancebo, G Del Peso Gilsanz, M Rodríguez, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 24, 2001
Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysisR Selgas, M A Bajo, M J Castro, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|August 21, 2001
Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivoM A Bajo, G del Peso, M A Castro, et al.
Pageof 5